Search Results (245)

Pigeon Newcastle disease poses a persistent threat to the global pigeon industry, underscoring the need for effective vaccination strategies. While both inactivated and DNA vaccines offer distinct advantages, the immunogenicity of a combined heterologous regimen remains underexplored. This study evaluated and compared three immunization strategies in pigeons: a DNA vaccine encoding the NDV F protein fused with chicken IL-18, an inactivated vaccine from a local virulent strain, and a DNA prime-inactivated boost regimen. The preparation workflows for both vaccine platforms are described in detail to provide methodological context for the immunological comparison. Critically, the prime–boost regimen elicited significantly higher hemagglutination inhibition (HI) antibody titers than either vaccine administered alone, demonstrating a clear synergistic effect. These findings highlight the complementary roles of the two platforms and provide a strong immunological rationale for further evaluation of this sequential strategy. Future studies incorporating viral challenge experiments and long-term immune monitoring are needed to determine whether the enhanced HI antibody response translates into protective efficacy under field conditions. Full article

Background/Objectives: Combined vaccination against avian influenza (A/H5N3, A/H7N7) and Newcastle disease is of practical interest for reducing handling during immunization and for achieving timely protection in poultry. The aim of this study was to evaluate an inactivated combined (associated) vaccine containing antigenic variants of avian influenza viruses A/H5N3 and A/H7N7 and Newcastle disease virus (NDV). The vaccine is protected by Patent No. 87417. Methods: Viruses with initial reproductive titers of 10^7.5 EID₅₀/mL were inactivated with formaldehyde and formulated as mono-, bi-, or trivalent combinations. Antigens were adsorbed onto aluminum hydroxide gel (1.5%). Immunogenicity was assessed in chicks naïve to avian influenza and Newcastle disease using hemagglutination inhibition (HI) antibody kinetics. Vaccination was performed twice with a 21-day interval. Group administration via drinking water (5 mL/bird) was compared with parenteral administration (1.0 mL/bird). Protective efficacy was evaluated by challenge with virulent viruses at day 30. Sterility and safety/reactogenicity were assessed, and immunobiological performance was additionally evaluated under household farm conditions (337 chickens). Results: Following vaccination, protective immunity was observed starting from day 14. HI titers peaked by day 30 (7.6–7.8 log₂ for A/H5N3 and A/H7N7; 9.2 log₂ for NDV) and remained detectable through 180 days (4.3–4.7 log₂ for avian influenza antigens; 5.1 log₂ for NDV). Group administration via drinking water produced antibody kinetics comparable to parenteral vaccination, and vaccinated birds were resistant to challenge at day 30. The tested batches met sterility requirements and showed acceptable safety/reactogenicity in laboratory studies. Conclusions: The developed inactivated combined vaccine induced HI antibodies and protective immunity against avian influenza (A/H5N3, A/H7N7) and Newcastle disease. The formulation concept supports flexible antigen combinations and enables group administration via drinking water, which may reduce handling compared with separate vaccinations. Full article

Background/Objectives: We previously developed a low-cost vaccine based on Newcastle disease virus expressing a stabilized pre-fusion spike of SARS-CoV-2 (NDV-HXP-S), which has shown safety and immunogenicity in pre-clinical and clinical studies. Due to the emergence of immune-evasive variants and the need to protect vulnerable populations, we evaluated adjuvanted NDV-HXP-S vaccine formulations to enhance and broaden immune responses. Methods: We tested the antibody responses of mice immunized intramuscularly with an inactivated NDV-HXP-S vaccine adjuvanted with AddaVax, AddaS03, Alhydrogel adjuvant 2% (Alum), or Quil-A. Results: AddaVax, AddaS03, and Alum induced the strongest IgG responses to the ancestral spike protein, boosted cross-reactive antibodies against both S1 and S2 subunits, and elicited high cross-neutralizing titers. Conclusions: The present results highlight the critical role of adjuvant selection in shaping both the magnitude and breadth of the immune response induced by the NDV-HXP-S vaccine. AddaVax, AddaS03, and Alum stand out as promising candidates to enhance NDV-HXP-S vaccine immunogenicity, with potential applications in booster strategies against SARS-CoV-2, enabling dose sparing and reducing costs. Full article

Chicken respiratory diseases represent multifactorial conditions resulting from viral, bacterial, mycoplasmal pathogens, and environmental factors, causing significant economic losses within the poultry industry. A specific respiratory disease characterized by breathing difficulties and bronchial occlusion due to caseous exudates is termed chicken bronchial obstruction. However, the absence of rapid, precise, and highly sensitive diagnostic methods for differentiation of primary respiratory disease pathogens or opportunistic pathogens, including avian influenza virus (AIV), infectious bronchitis virus (IBV), Pseudomonas aeruginosa (P. aeruginosa), and Escherichia coli (E. coli), constitutes a substantial challenge. This study developed a quadruplex droplet digital polymerase chain reaction (ddPCR) method that targeted the HA gene of H9 subtype AIV, the M gene of IBV, the Pal gene of P. aeruginosa, and the UidA gene of E. coli. Following the optimization of annealing temperature, sensitivity, and repeatability, the minimum detectable concentrations were determined as 3.02 copies/μL for the HA gene of H9 subtype AIV, 3.08 copies/μL for the M gene of IBV, 3.19 copies/μL for the Pal gene of P. aeruginosa, 3.39 copies/μL for the UidA gene of E. coli. No cross-reactivity was observed with Newcastle disease virus (NDV), H5 subtype AIV, H7 subtype AIV, fowl adenovirus serotype 4 (FAdV-4), infectious laryngotracheitis virus (ILTV), Avibacterium paragallinarum, Streptococcus, Salmonella, Pasteurella multocida, and Staphylococcus aureus. The method demonstrated excellent repeatability, with a coefficient of variation (CV) below 9%. The 185 clinical samples collected in Hebei Province China are tested by both quadruplex ddPCR and quadruplex qPCR method and the results compared. The sensitivity of the quadruplex ddPCR method (57.30%; 106/185) slightly exceeded that of the quadruplex qPCR method (49.73%; 92/185). Pathogens or opportunistic pathogens positive rates obtained via the quadruplex ddPCR were 40.00% for H9 subtype AIV, 33.51% for IBV, 24.32% for P. aeruginosa, and 27.57% for E. coli. In comparison, the positive rates of H9 subtypes AIV, IBV, P. aeruginosa, and E. coli from the quadruplex qPCR were 36.22%, 30.81%, 21.62%, and 24.32%, respectively. The coincidence rates between the two methods were 96.22% for H9 AIV, 97.30% for IBV, 97.30% for P. aeruginosa, and 96.76% for E. coli. These results demonstrated that the quadruplex ddPCR method represented a highly sensitive, specific, and rapid technique for identifying H9 subtype AIV, IBV, P. aeruginosa, and E. coli. Full article

Background/Objective: The poultry industry requires extensive vaccination of chickens against IBV in an effort to prevent the disease in animals and significant economic losses. Current vaccination strategies often lack effectiveness, and the continual emergence of new IBV variants makes disease control increasingly challenging. We have developed an inactivated vaccine for poultry containing nine different antigens (Nobilis Multriva), including two IBDV strains, two ARV strains, one NDV strain, one AMPV strain, one EDSV strain and two IBV strains: M41 (genotype GI-1) and 4–91 (genotype GI-13). In this study, the IB efficacy of this novel inactivated vaccine was investigated against homologous and heterologous IBV strains. Methods: Inactivated IBV vaccine containing the M41 and 4–91 strains (Nobilis Multriva) was administered intramuscularly, either alone or following vaccine priming, in SPF and commercial chickens. Birds were challenged with homologous and heterologous IBV strains at defined ages (peak of lay, mid-lay and end of lay). Vaccine efficacy was evaluated through serological assays, clinical observations, and monitoring of egg production post-challenge. Results: This vaccine provided excellent broad protection against different IBV strains circulating in different parts of the world, including IBV M41, 4–91, QX, Q1 and Var2. Furthermore, the vaccine provided long-lasting IBV serological response against IB M41 and IB 4–91 until at least 96 weeks of age in SPF and commercial layers and breeder birds. This vaccine will allow farmers to reduce the number of vaccination moments, thereby minimizing stress to the birds, while also decreasing labor demands and the risk of human error, ultimately contributing to lower overall vaccination costs. Conclusions: Given its demonstrated broad cross-protection and sustained serological responses, this nine-valent inactivated vaccine (Nobilis Multriva) represents a key component of an effective vaccination regimen for controlling IBV infections in the poultry industry. Full article

Species of the orders Charadriiformes and Anseriformes serve as the primary long-distance disseminators of various avulaviruses. The most economically significant among them is Newcastle disease virus (NDV), or Avian orthoavulavirus 1 (AOAV-1), which causes diseases of varying severity in both domestic and wild birds. Other avulaviruses have been studied to a much lesser extent, and for most of them, only single isolates are known, which does not allow a comprehensive assessment of their potential threat. To evaluate the biological diversity and potential risks posed by avian paramyxoviruses spread by wild waterfowl during autumn migration, fecal samples from mallards (Anas platyrhynchos) (n = 3604) were collected at water bodies in Moscow and the Moscow Region between 2008 and 2024. From these samples, AOAV-1 (n = 4) and Avian paraavulavirus 4 (APMV-4) (n = 9) were isolated and partially sequenced. Phylogenetic analysis revealed that all AOAV-1 isolates belong to genotype 1 of class II, while all APMV-4 isolates belong to the Eurasian subgenotype of genotype 1. Analysis of the F protein cleavage site motif indicated conformity with the consensus sequences characteristic of lentogenic and non-pathogenic avian paramyxoviruses in all isolates. Full article

Genotype VII Newcastle disease virus (NDV) has been confirmed as the predominant epidemic strain in China. Traditional vaccine strains fail to provide complete immune protection when challenged with an epidemic strain. NDV vaccines with phylogenetic relationships closer to those of the endemic viruses demonstrate improved protective efficacy in reducing viral shedding and transmission. This research seeks to develop attenuated vaccine strains that are specifically aligned with NDV genotype VII. A reverse genetics system for the genotype VII NDV HB strain was developed, successfully rescuing the attenuated recombinant virus aHB by substituting the fusion protein (F) cleavage site motif “¹¹²R-R-Q-K-R↓F¹¹⁷” with “¹¹²G-R-Q-G-R↓L¹¹⁷.” Recombinant aHB virus attenuation was verified by assessing the mean death time (MDT) and intracerebral pathogenicity index (ICPI). The attenuated aHB strain demonstrated greater proliferation titers than did the virulent HB and rHB strains both in vivo and in vitro. Furthermore, the genome exhibited significant genetic stability even after 10 passages in chicken embryos. When challenged with the HB strain of NDV genotype VII, the aHB-inactivated vaccine provided 100% protection to chickens and effectively prevented viral shedding. These findings indicate that recombinant aHB may serve as an effective vaccine candidate. Full article

Previous studies have demonstrated that polysaccharides used as feed additives can promote poultry growth. This study evaluated the effects of different doses of Curculigo orchioides Polysaccharide (COP) on growth performance, antioxidant capacity, immune function, intestinal health and related mechanisms in 1 to 35 days old Wenchang female chicks. A total of 120 female Wenchang chickens (1 day old) were assigned to three treatment groups, with 5 replicates per group and 8 chickens per replicate. The Wenchang chickens were fed a basal diet (control) supplemented with either a low dose of Curculigo orchioides Polysaccharide (400 mg/kg) or a high dose (800 mg/kg) for 5 weeks. Purified COP is composed of mannose (68.97%), glucose (24.38%), galactose (6.34%), and arabinose (0.32%). Results showed that high-dose COP supplementation significantly increased Wenchang chicken body weight (p < 0.05) and feed intake (p < 0.05); reduced feed conversion ratio (p < 0.05); increased small intestinal villus height and tight junction protein expression levels; enhanced muscle fiber cross-sectional area (p < 0.05); improved total antioxidant capacity (p < 0.01); decreased serum malondialdehyde levels (p < 0.01), tumor necrosis factor-α (p < 0.0001), and pro-inflammatory cytokine interleukin-6 levels (p < 0.05); and elevated antibody titers against Newcastle disease virus at 21, 28, and 35 days (p < 0.01). It also elevated the protein phosphorylation levels of the PI3K/Akt/mTOR pathway (p < 0.0001) and enriched beneficial gut microbiota that may mediate this pathway activation. Analysis of the cecal microbiota in Wenchang female chicks revealed that the high-dose COP group enriched Oscillospira and Lactobacillus. In conclusion, high-dose COP improves growth performance and antioxidant capacity of Wenchang chicks, enhances immunity against NDV, enriches beneficial gut microbiota, and promotes growth by activating the PI3K/Akt/mTOR pathway. Full article

The diseases caused by genotype VII Newcastle disease virus (NDV), H9N2 avian influenza virus (AIV), and fowl adenovirus serotype 4 (FAdV-4) continue to threaten the global poultry industry. However, no broad-spectrum vaccines provide simultaneous protection against these three pathogens. This study employed bioinformatics and immunoinformatics approaches to design a multi-epitope vaccine, named NFAF, which consists of B-cell, cytotoxic T lymphocyte (CTL) epitopes, and helper T lymphocyte (HTL) epitopes derived from hemagglutinin-neuraminidase (HN) and fusion (F) proteins of genotype VII NDV, hemagglutinin (HA) protein of H9N2, and Fiber2 protein of FAdV-4. The vaccine candidate was predicted to have non-allergenic properties, non-toxicity, high antigenicity, and favorable solubility. Each of its constituent antigenic epitopes has a high degree of conservation. Molecular docking demonstrated stable binding between NFAF and chicken Toll-like receptor (TLRs) and major histocompatibility complex (MHC) molecules. NFAF was expressed in soluble form in Escherichia coli and purified. Polyclonal antibodies against all three target viruses showed specific binding to NFAF. In vitro experiments revealed that NFAF effectively stimulated chicken peripheral blood mononuclear cells (PBMCs) and induced Th1, Th2, and pro-inflammatory cytokine production, confirming its immunogenicity, and increased the mRNA expression of the key signaling molecules MyD88 and NF-κB. These results suggested that NFAF could therefore be an efficacious multi-epitope vaccine against genotype VII NDV, H9N2, and FAdV-4 infections. Full article

The rapid emergence and evolution of avian viral pathogens present a major challenge to global poultry health and food security. Traditional vaccine development is often slow, costly, and limited by antigenic diversity. In this study, we present a comprehensive artificial intelligence (AI)-driven pipeline for the rational design, modeling, and optimization of multi-epitope vaccines targeting economically important RNA and DNA viruses affecting poultry, including H5N1, NDV, IBV, IBDV, CAV, and FPV. We utilized advanced machine learning and deep learning tools for epitope prediction, antigenicity assessment, and structural modeling (via AlphaFold2), and codon optimization. B-cell and T-cell epitopes were selected based on binding affinity, conservation, and immunogenicity, while adjuvants and linker sequences enhanced construct stability and immune response. In silico immune simulations forecasted robust humoral and cellular responses, including cytokine production and memory cell activation. The study also highlights challenges such as data quality, model interpretability, and ethical considerations. Our work demonstrates the transformative potential of AI in veterinary vaccinology and offers a scalable model for rapid, data-driven vaccine development against avian diseases. Full article

Between 2019 and 2023, 163 cases of subgenotype VII.1.1 Newcastle disease virus infection were registered in backyard poultry in the Russian Federation within the framework of epizootiological monitoring. Subgenotype VII.1.1 Newcastle disease virus was reported in a total of 18 different subjects of the Russian Federation. Most of the Newcastle disease outbreaks caused by the viruses of this subgenotype occurred in the autumn and winter period (60%). Further tests allowed for the determination of complete F and HN gene nucleotide sequences for 40 isolates. The results were used to perform the Bayesian analysis of F gene sequences with BEAST v.1.10.4 software. The obtained nucleotide substitution accumulation rates were practically non-dependent on the selected nucleotide substitution model and varied appreciably depending on the applied molecular clock model (0.0018 and 0.002 site-1year-1). The conducted study established that the formation of the ‘Russian’ NDV isolates of subgenotype VII.1.1 followed several stages. In the early 2000s, ancestral viruses belonging to subgenotype VII-d were detected in the Middle East and Eastern Europe. From these, through intermediate forms identified in Iraq around 2007–2008, a group designated as subgenotype VII-L emerged. This group gave rise to two sister clades: the Iranian subgenotype VII-L and the cluster of isolates from Russia and Poland, whose immediate common ancestor likely existed around 2015–2016, probably in Asia. Full article

This study reports the synthesis of high cis-1,4 polybutadiene with a narrow molecular weight distribution (Đ < 2.0) by coordinative chain transfer polymerization (CCTP) using a homogeneous ternary NdV₃/diisobutyl aluminum hydride (DIBAH)/dimethyldichlorosilane (Me₂SiCl₂) Ziegler–Natta catalyst system. The polymerization parameters, notably the monomer-to-initiator ratio ([M]/[Nd]) and the halogen-to-initiator ratio ([Cl]/[Nd]), were systematically varied to define the CCTP operational window. It was found that CCTP conditions are achieved only at low [M]/[Nd] ratios (<2500) and intermediate [Cl]/[Nd] ratios between 1.0 and 2.0, facilitating the production of polymers with molecular weights below 32 kDa and narrow dispersity. Increasing these ratios beyond these thresholds potentially induces the formation of insoluble, hyper-halogenated catalytic species and increases medium viscosity, which significantly broadens the molecular weight distribution (Đ > 4.0) and impairs CCTP control. These findings challenge previous assumptions that higher halogen concentrations are necessary for CCTP, thereby providing important mechanistic insights for tuning active species and achieving improved polymer architecture. The work demonstrates a viable pathway to control polymer microstructure and molecular weight in neodymium-based CCTP, which is critical for design of high-performance elastomeric materials. Full article

The Newcastle disease virus (NDV), an avian paramyxovirus, induces the highly contagious Newcastle disease in poultry. Newcastle disease outbreaks, common in many developing countries, have been recorded worldwide for a century. Poultry, even vaccinated stocks, together with wild and synanthropic birds, serve as reservoirs of NDV. Despite the extensive use of commercial NDV vaccines, Newcastle disease outbreaks frequently occur in vaccinated chickens, resulting in great economic losses. The primary limitation of commercial Newcastle disease vaccines is their restricted compatibility with emerging novel NDV strains. The advancement of vaccines and vaccination techniques is anticipated to reduce the propagation of pathogenic NDV strains and consequently alleviate losses in poultry production. This review examines the NDV genotypes and strains implicated in both current and historical Newcastle disease outbreaks, and evaluates existing and candidate NDV vaccines, emphasizing recent innovations and novel techniques. Our aim was to delineate critical subjects for future inquiry and to furnish extensive data that could aid researchers in understanding the current advancements and existing problems in Newcastle disease vaccination prophylactics. The emergence of a new generation of vaccines employing advanced technologies may substantially improve the efficacy of Newcastle disease prevention and control. Full article

Newcastle disease (ND) is a highly contagious and economically significant viral infection that affects poultry globally, with recurrent outbreaks occurring even among vaccinated flocks in Egypt. Caused by the Newcastle disease virus (NDV), the disease results in substantial losses due to high mortality rates, decreased productivity, and the imposition of trade restrictions. This study aimed to develop a rapid, sensitive, and field-deployable diagnostic assay based on real-time reverse transcription recombinase-aided amplification (RT-RAA) for the detection of all NDV genotypes in clinical avian specimens. Primers and an exo-probe were designed based on the most conserved region of the NDV matrix gene. After testing ten primer combinations, the pair NDV RAA-F1 and RAA-R5 demonstrated the highest sensitivity, detecting as low as 6.89 EID₅₀/mL (95% CI). The RT-RAA assay showed excellent clinical sensitivity and specificity, with no cross-reactivity to other common respiratory pathogens such as avian influenza virus, infectious bronchitis virus, Mycoplasma gallisepticum or infectious laryngotracheitis virus. All 25 field samples that were tested positive by real-time RT-PCR, including those with high CT values (~35), were detected by RT-RAA in 2–11 min, indicating superior sensitivity and speed. The assay requires only basic equipment and can be performed under isothermal conditions, making it highly suitable for on-site detection in resource-limited or rural settings. The successful implementation of RT-RAA can improve NDV outbreak response, support timely vaccination strategies, and enhance disease control efforts. Overall, the assay presents a promising alternative to conventional diagnostic methods, contributing to the sustainability and productivity of the poultry sector in endemic regions. Full article

Newcastle Disease (ND) is an important and notable disease among the avian infectious diseases, because of its high contagiousness, and the most virulent strains of ND virus (NDV) have impacted poultry breeders all over the world. Immunization and biosecurity measures are used to reduce ND; however, vaccination has been shown to offer protection against clinical signs but not against virus proliferation and shedding, which could have an adverse effect on the environment. The genetic basis for inherent resistance to NDV has been established, and genetic selection on existing resistance-related genetic variation can help to mitigate virus propagation. Further, understanding the genes and processes that drive the response to NDV will lay the groundwork for genetic improvement in poultry. The majority of studies on NDV susceptibility make use of phenotypic indicators such as body weight, morbidity, mortality, antibody response, and viral load. According to recent advancements in molecular genetic research, many different genes are diversely regulated in different chicken lines to NDV infection, which might be used in the future to establish disease-resistant breeding approaches. It is possible that many more genes linked to illness and resistance are still to be discovered, because the precise mechanism of resistance is not entirely understood. The enhanced genetic knowledge of chickens and the development of more advanced transgenic techniques would lead to pathogen resistance. Hence, this paper summarizes the current understanding of genetic resistance to Newcastle Disease, and we additionally highlight a few possible genes/markers connected with NDV that may improve chicken resistance to NDV infections and can be used to produce NDV-resistant chicken breeds/strains in the near future. Full article